Læknablaðið - 15.09.1983, Blaðsíða 53

LÆKNABLAÐIÐ
223
öðrum aðferðum verður beitt en áður hafa
verið reyndar. Hvort tilraunin gefur árangur
getur aðeins tíminn leitt í ljós, en reynist pað
vera, hafa þær þjóðir, sem taka þátt í tilraun-
inni, fengið um 10-15 ára forskot.
HEIMILDIR
1. Report on a WHO Meeting Copenhgen 4.-8. Oct.
1982 (ICP/CVD 018 (8)). WHO/EURO.
2. Report on a WHO Meeting Geneve 25.-28. OCT.
1982. (NCD/83.1). WHO/GENEVE.
3. Jackson, RH. Aspects of the Preventation of
Noncommunicable Diseases Including Accidents.
(ICP/CVD 018 (8) 16, Rev. 1.) WHO/EURO.
4. Sigurðsson P. Guidance for Protocol for Coun-
try-wide Integrated Programme for the Preven-
tion and Control of Noncommunicable Diseases.
(ICP/CVD 018 (11) (12) (13) (16)) WHO/EURO.
5. Tuomiletho J. Information, Systems and Monito-
ring and Evaluation Methods in Country-wide
Integrated Programmes for the Prevention and
Control af Noncommunicable Diseases.
(ICP/CVD 018 (12) 7) WHO/EURO.
CLINICAL CYTOPATHOLOGY FOR
PATHOLOGISTS
1984 POSTGRADUATE COURSE
The Twenty-fifth Postgraduate Institute for
Pathologists in Clinical Cytopathology is to be
given at The Johns Hopkins University School
of Medicine and The Johns Hopkins Hospital,
Baltimore, Maryland, March 25-April 6, 1984.
The full two week program is designed for
pathologists who are Certified (or qualified)
by the American Board of Pathology (PA), or
its international equivalent.
It will provide an intensive refresher in all
aspects of the field of Clinical Cytopathology,
with time devoted to newer techniques, spe-
cial problems, and recent applications. Topics
will be covered in lectures, explored in smail
informal conferences, and discussed over the
microscope with the Faculty. Self-instructional
material will be available to augment at
individual pace. A loan set of slides with text
will be sent to each participant within the
United States and Canada for home-study
during February and March before the Insti-
tute. Special arrangements will apply to partici-
pants outside the United States. Credit hours
147 in AMA Category 1.
Application is advised before January 31,
1984, and must be made before February 22,
1984.
For details, write: John K. Frost, M.D., 604
Pathology Building, The Johns Hopkins Ho-
spital, Baltimore, Maryland 21205, U.S.A.
The entire Course is given in English.
NEWS RELEASE
The Laerdal Foundation for Acute Medicine
has been instituted with the purpose of
providing financial support to research or
development projects in the field of acute
medicine. Available grants this year exceed
US $ 200,000.
Projects to be considered for support may
include experimental or clinical studies, educa-
tional activities, practical improvements of
patient transport and publication of ideas and
findings. Pre-hospital projects may be pre-
ferred.
The foundation is governed by a board of
appointed members from the following orga-
nizations:
— The Faculty of Medicine of the University
of Oslo
— The Scandinavian Society of Anaesthesio-
logists
— The Society of Critical Care Medicine
(USA)
— The Asmund S. Laerdal Company
Deadline for applications bi-annually by Oct. 1
and April 1. Application form and further
information may be obtained from:
The Laerdal Foundation for Acute Medicine
P.O. Box 377
N-4001 Stavanger, Norway